GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XSWX:NWRN) » Definitions » Total Assets

Newron Pharmaceuticals SpA (XSWX:NWRN) Total Assets : CHF24.39 Mil (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Newron Pharmaceuticals SpA Total Assets?

Newron Pharmaceuticals SpA's Total Assets for the quarter that ended in Dec. 2023 was CHF24.39 Mil.

During the past 12 months, Newron Pharmaceuticals SpA's average Total Assets Growth Rate was -12.10% per year. During the past 3 years, the average Total Assets Growth Rate was -16.60% per year. During the past 5 years, the average Total Assets Growth Rate was -9.80% per year. During the past 10 years, the average Total Assets Growth Rate was 4.80% per year.

During the past 13 years, Newron Pharmaceuticals SpA's highest 3-Year average Total Assets Growth Rate was 69.50%. The lowest was -41.50%. And the median was 3.95%.

Total Assets is connected with ROA %. Newron Pharmaceuticals SpA's annualized ROA % for the quarter that ended in Dec. 2023 was -63.47%. Total Assets is also linked to Revenue through Asset Turnover. Newron Pharmaceuticals SpA's Asset Turnover for the quarter that ended in Dec. 2023 was 0.12.


Newron Pharmaceuticals SpA Total Assets Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Total Assets Chart

Newron Pharmaceuticals SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.82 55.33 52.54 36.71 24.39

Newron Pharmaceuticals SpA Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.54 44.66 36.71 30.72 24.39

Newron Pharmaceuticals SpA Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Newron Pharmaceuticals SpA's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=-28.205+52.599
=24.39

Newron Pharmaceuticals SpA's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=-28.205+52.599
=24.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Newron Pharmaceuticals SpA  (XSWX:NWRN) Total Assets Explanation

Total Assets is connected with ROA %.

Newron Pharmaceuticals SpA's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-17.492/( (30.723+24.394)/ 2 )
=-17.492/27.5585
=-63.47 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Newron Pharmaceuticals SpA's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=3.36/( (30.723+24.394)/ 2 )
=3.36/27.5585
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Newron Pharmaceuticals SpA Total Assets Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Newron Pharmaceuticals SpA (XSWX:NWRN) Business Description

Traded in Other Exchanges
Address
Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
Executives
Patrick Langlois Supervisory Board

Newron Pharmaceuticals SpA (XSWX:NWRN) Headlines

No Headlines